GEHC GE Healthcare Technologies Inc.

Fundamentals / CIK 0001932393 / USD

GE Healthcare Technologies Inc. reported $21.64B in revenue and net income of $2.15B for the trailing twelve months ended September 30, 2026 (up 7.2% year over year), with a 39.9% gross margin and a 13.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open GEHC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$20.33B$10.16B$0FY 2021 Revenue: $17.59BFY 2021 Net Income: $2.25B2021FY 2022 Revenue: $18.34BFY 2022 Net Income: $1.92B2022FY 2023 Revenue: $19.55BFY 2023 Net Income: $1.57B2023FY 2024 Revenue: $19.67BFY 2024 Net Income: $1.99B2024FY 2025 Revenue: $20.62BFY 2025 Net Income: $2.08B2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $20.62B $19.67B $19.55B $18.34B $17.59B
Gross Profit $8.25B $8.21B $7.92B $7.18B $7.17B
Research & Development $1.26B $1.31B $1.21B $1.03B $816.0M
Selling, General & Admin $4.22B $4.27B $4.28B $3.63B $3.56B
Total Operating Expenses $5.49B $5.58B $5.49B $4.66B $4.38B
Operating Income $2.76B $2.62B $2.44B $2.52B $2.79B
EBITDA $3.34B $3.21B $3.04B $3.15B $3.42B
Interest Expense $440.0M $504.0M $542.0M $77.00M $40.00M
Income Before Tax $2.77B $2.58B $2.36B $2.51B $2.88B
Income Tax Expense $614.0M $531.0M $743.0M $563.0M $600.0M
Net Income $2.08B $1.99B $1.57B $1.92B $2.25B
Basic EPS $4.56 $4.37 $3.05 $4.22 $4.95
Diluted EPS $4.55 $4.34 $3.03 $4.22 $4.95
Basic Shares Outstanding 456.0M 456.0M 455.0M 454.0M 454.0M
Diluted Shares Outstanding 458.0M 459.0M 458.0M 454.0M 454.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $5.51B $5.29B $5.13B $5.70B $5.14B $5.01B $4.78B $5.32B
Gross Profit $2.22B $2.18B $1.98B $2.26B $1.99B $1.99B $2.01B $2.27B
Research & Development $320.0M $323.0M $345.0M $323.0M $292.0M $302.0M $344.0M $344.0M
Selling, General & Admin $1.10B $1.12B $1.12B $1.11B $1.04B $1.03B $1.04B $1.13B
Total Operating Expenses $1.42B $1.44B $1.46B $1.43B $1.34B $1.33B $1.38B $1.47B
Operating Income $805.0M $739.0M $515.0M $827.0M $653.0M $654.0M $629.0M $801.0M
EBITDA $968.0M $899.0M $668.0M $973.0M $802.0M $802.0M $765.0M $941.0M
Interest Expense $122.0M $114.0M $96.00M $105.0M $111.0M $113.0M $110.0M $121.0M
Income Before Tax $752.0M $693.0M $505.0M $821.0M $643.0M $613.0M $692.0M $834.0M
Income Tax Expense $129.0M $119.0M $94.00M $219.0M $179.0M $113.0M $104.0M $96.00M
Net Income $615.0M $561.0M $389.0M $589.0M $446.0M $486.0M $564.0M $721.0M
Basic EPS $1.36 $1.24 $0.85 -- $0.98 $1.06 $1.23 --
Diluted EPS $1.36 $1.24 $0.85 -- $0.98 $1.06 $1.23 --
Basic Shares Outstanding 452.0M 453.0M 456.0M -- 456.0M 457.0M 457.0M --
Diluted Shares Outstanding 453.0M 454.0M 457.0M -- 457.0M 458.0M 459.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $4.49B $2.87B $2.49B $1.44B
Cash & Short-Term Investments $4.49B $2.87B $2.49B $1.44B
Inventory $2.23B $1.94B $1.96B $2.15B
Other Current Assets $726.0M $532.0M $389.0M $417.0M
Total Current Assets $12.50B $9.90B $9.41B $8.32B
Property, Plant & Equipment, Net -- -- $2.14B $2.00B
Goodwill $13.49B $13.14B $12.94B $12.81B
Intangible Assets $1.13B $1.08B $1.25B $1.52B
Long-Term Investments $351.0M $373.0M $357.0M $322.0M
Other Non-Current Assets $2.21B $1.95B $1.88B $1.02B
Total Non-Current Assets $24.41B $23.19B $23.04B $19.22B
Total Assets $36.91B $33.09B $32.45B $27.54B
Accounts Payable $3.25B $3.04B $2.95B $2.94B
Short-Term Debt $1.01B $3.00B $2.01B $22.00M
Deferred Revenue (Current) $2.10B $1.94B $1.92B $1.90B
Other Current Liabilities $1.59B $1.55B -- $2.19B
Total Current Liabilities $9.11B $9.55B $8.98B $7.19B
Long-Term Debt $9.49B $7.45B $8.44B $8.23B
Deferred Revenue (Non-Current) $803.0M $686.0M $705.0M $630.0M
Other Non-Current Liabilities $2.06B $1.80B $1.88B $1.60B
Total Non-Current Liabilities $17.20B $14.88B $16.16B $10.76B
Total Liabilities $26.31B $24.44B $25.14B $17.95B
Total Debt (incl. Leases) $10.97B $10.88B $10.87B $8.64B
Common Stock $5.00M $5.00M $5.00M $0
Retained Earnings $5.28B $3.26B $1.33B $0
Accumulated Other Comp. Income -$1.39B -$1.38B -$691.0M -$1.88B
Total Stockholders' Equity $10.38B $8.45B $7.13B $9.36B
Total Equity $10.39B $8.46B $7.14B $9.36B

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $2.83B $2.08B $2.26B $4.49B $4.00B $3.74B $2.45B $2.87B
Cash & Short-Term Investments $2.83B $2.08B $2.26B $4.49B $4.00B $3.74B $2.45B $2.87B
Inventory $2.63B $2.48B $2.35B $2.23B $2.30B $2.28B $2.16B $1.94B
Other Current Assets $723.0M $793.0M $842.0M $726.0M $702.0M $638.0M $601.0M $532.0M
Total Current Assets $11.49B $10.50B $10.43B $12.50B $11.89B $11.31B $9.73B $9.90B
Goodwill $15.14B $15.10B $15.06B $13.49B $13.44B $13.42B $13.37B $13.14B
Intangible Assets $1.81B $1.89B $1.91B $1.13B $1.16B $1.22B $1.24B $1.08B
Long-Term Investments $383.0M $362.0M $352.0M $351.0M $302.0M $244.0M $235.0M $373.0M
Other Non-Current Assets $2.28B $2.25B $2.25B $2.21B $2.15B $2.08B $1.93B $1.95B
Total Non-Current Assets $26.88B $26.75B $26.70B $24.41B $24.23B $24.19B $23.85B $23.19B
Total Assets $38.37B $37.25B $37.12B $36.91B $36.13B $35.50B $33.59B $33.09B
Accounts Payable $3.32B $3.23B $3.41B $3.25B $2.99B $2.98B $3.15B $3.04B
Short-Term Debt $5.00M $4.00M $9.00M $1.01B $4.01B $4.01B $4.00B $3.00B
Deferred Revenue (Current) $2.25B $2.20B $2.15B $2.10B $2.00B $1.98B $1.89B $1.94B
Other Current Liabilities $1.61B $1.43B $1.54B $1.59B $1.54B $1.43B $1.58B $1.55B
Total Current Liabilities $8.81B $8.30B $8.53B $9.11B $10.07B $9.75B $9.97B $9.55B
Long-Term Debt $9.97B $10.09B $10.13B $9.49B $8.28B $8.27B $6.76B $7.45B
Deferred Revenue (Non-Current) $895.0M $857.0M $819.0M $803.0M $775.0M $741.0M $724.0M $686.0M
Other Non-Current Liabilities $2.30B $2.13B $2.02B $2.06B $2.10B $2.00B $1.84B $1.80B
Total Non-Current Liabilities $17.69B $17.73B $17.70B $17.20B $15.83B $15.80B $14.20B $14.88B
Total Liabilities $26.51B $26.03B $26.23B $26.31B $25.91B $25.55B $24.17B $24.44B
Total Debt (incl. Leases) $10.41B $10.54B $10.58B $10.97B $12.75B $12.72B $11.19B $10.88B
Common Stock $5.00M $5.00M $5.00M $5.00M $5.00M $5.00M $5.00M $5.00M
Retained Earnings $6.79B $6.20B $5.65B $5.28B $4.71B $4.29B $3.81B $3.26B
Accumulated Other Comp. Income -$1.46B -$1.48B -$1.40B -$1.39B -$1.16B -$1.09B -$1.20B -$1.38B
Total Stockholders' Equity $11.61B $10.97B $10.67B $10.38B $9.99B $9.71B $9.19B $8.45B
Total Equity $11.63B $10.99B $10.68B $10.39B $10.02B $9.73B $9.21B $8.46B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $2.15B $2.05B $1.61B $1.97B $2.29B
Depreciation & Amortization $578.0M $580.0M $610.0M $633.0M $625.0M
Stock-Based Compensation $130.0M $125.0M $114.0M $67.00M $76.00M
Change in Inventory -$142.0M -$81.00M $111.0M -$402.0M -$435.0M
Change in Payables $90.00M $60.00M -$100.0M $481.0M $263.0M
Operating Cash Flow $1.99B $1.96B $2.10B $2.13B $1.61B
Capital Expenditure -$482.0M -$401.0M -$387.0M -$310.0M -$248.0M
Free Cash Flow $1.50B $1.55B $1.71B $1.82B $1.36B
Acquisitions, Net -$378.0M -$313.0M -$147.0M $0 -$1.48B
Purchases of Investments -$118.0M -$40.00M -$48.00M -$59.00M --
Investing Cash Flow -$1.05B -$914.0M -$558.0M -$398.0M -$1.76B
Share Repurchases -$200.0M $0 $0 -- --
Dividends Paid -$64.00M -$55.00M -$41.00M $0 $0
Financing Cash Flow $617.0M -$573.0M -$478.0M -$822.0M -$263.0M
Net Change in Cash $1.62B $387.0M $1.05B $890.0M -$451.0M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $623.0M $573.0M $411.0M $602.0M $464.0M $500.0M $588.0M $738.0M
Depreciation & Amortization $163.0M $160.0M $153.0M $146.0M $149.0M $148.0M $136.0M $140.0M
Stock-Based Compensation $36.00M $45.00M $35.00M $36.00M $38.00M $34.00M $22.00M $33.00M
Change in Inventory -$120.0M -$139.0M -$171.0M $75.00M -$29.00M -$34.00M -$154.0M $76.00M
Change in Payables $61.00M -$200.0M $221.0M $209.0M -$6.00M -$259.0M $146.0M $127.0M
Operating Cash Flow $907.0M $168.0M $290.0M -- $593.0M $94.00M $250.0M --
Capital Expenditure -$114.0M -$100.0M -$178.0M -$134.0M -$110.0M -$86.00M -$152.0M -$102.0M
Free Cash Flow $793.0M $68.00M $112.0M -- $483.0M $8.00M $98.00M --
Acquisitions, Net $0 $4.00M -$2.30B -$99.00M $0 -$10.00M -$269.0M -$54.00M
Purchases of Investments -$33.00M -$6.00M -$13.00M -$36.00M -$54.00M -$8.00M -$20.00M -$7.00M
Investing Cash Flow -$111.0M -$115.0M -$2.50B -$269.0M -$148.0M -$223.0M -$407.0M -$240.0M
Share Repurchases $0 -$200.0M -$100.0M $0 -$100.0M -$100.0M $0 --
Dividends Paid -$16.00M -$16.00M -$16.00M -$16.00M -$16.00M -$16.00M -$16.00M -$14.00M
Financing Cash Flow -$40.00M -$236.0M $21.00M -$293.0M -$165.0M $1.36B -$286.0M -$1.28B
Net Change in Cash $749.0M -$180.0M -$2.23B $486.0M $264.0M $1.29B -$416.0M -$679.0M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 40.0% 41.7% 40.5% 39.1% 40.8%
Operating Margin 13.4% 13.3% 12.5% 13.8% 15.9%
Net Profit Margin 10.1% 10.1% 8.0% 10.4% 12.8%
Return on Equity (ROE) 20.1% 23.6% 22.0% 20.5% --
Return on Assets (ROA) 5.6% 6.0% 4.8% 7.0% --
Current Ratio 1.37x 1.04x 1.05x 1.16x --
Quick Ratio 1.13x 0.83x 0.83x 0.86x --
Debt to Equity 1.06x 1.29x 1.52x 0.92x --
Revenue Growth (YoY) +4.8% +0.6% +6.6% +4.3% --
Gross Profit Growth (YoY) +0.5% +3.6% +10.3% +0.1% --
Operating Income Growth (YoY) +5.3% +7.8% -3.4% -9.8% --
Net Income Growth (YoY) +4.6% +27.1% -18.2% -14.7% --
EPS Growth (YoY) +4.3% +43.3% -27.7% -14.7% --
Operating Cash Flow Growth (YoY) +1.6% -6.9% -1.5% +32.8% --
Free Cash Flow Growth (YoY) -3.2% -9.3% -6.0% +34.2% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 39.9% 39.5% 39.1% 40.0% 40.8% 41.6% 42.0% 41.7%
Operating Margin 13.3% 12.9% 12.6% 13.4% 13.5% 13.8% 13.7% 13.3%
Net Profit Margin 10.0% 9.3% 9.1% 10.1% 11.0% 11.2% 11.0% 10.1%
Return on Equity (ROE) 18.5% 18.1% 17.9% 20.1% 22.2% 23.1% 23.8% 23.6%
Return on Assets (ROA) 5.6% 5.3% 5.1% 5.6% 6.1% 6.3% 6.5% 6.0%
Current Ratio 1.30x 1.26x 1.22x 1.37x 1.18x 1.16x 0.98x 1.04x
Quick Ratio 1.01x 0.97x 0.95x 1.13x 0.95x 0.93x 0.76x 0.83x
Debt to Equity 0.90x 0.96x 0.99x 1.06x 1.28x 1.31x 1.22x 1.29x
Revenue Growth (YoY) +7.2% +5.8% +7.4% +7.1% +5.8% +3.5% +2.7% +2.2%
Gross Profit Growth (YoY) +11.8% +9.8% -1.7% -0.6% -1.8% -0.8% +5.8% +5.5%
Operating Income Growth (YoY) +23.3% +13.0% -18.1% +3.2% -3.4% +7.6% +16.5% +16.3%
Net Income Growth (YoY) +37.9% +15.4% -31.0% -18.3% -5.1% +13.6% +50.8% +78.9%
EPS Growth (YoY) +38.8% +17.0% -30.9% -- -4.9% +12.8% +50.0% --
Operating Cash Flow Growth (YoY) +53.0% +78.7% +16.0% -- -- -- -40.3% --
Free Cash Flow Growth (YoY) +64.2% +750.0% +14.3% -- -- -- -64.2% --
Source: SEC EDGAR CompanyFacts (CIK 0001932393) · from December 31, 2021 Data through September 30, 2026 · synced Nov 20, 2026, 05:04 UTC · Open in terminal